Please assess the completion status of the following clinical trial:

Trial Title: BiliCam Clinical Validation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Newborn born at ≥ 35 weeks gestation~* Parent speaks and reads English~* Parent provides written informed consent~Exclusion Criteria:~* previous or ongoing treatment with phototherapy for hyperbilirubinemia~* Medical or other complications that preclude completion of the study

- Gender: ALL
- Minimum Age: 0 Hours
- Maximum Age: 191 Hours
- Healthy Volunteers: t

Study Arms:
- Newborns (Type: EXPERIMENTAL): Newborns will be enrolled in the study in 2 different ways. At Staged Enrollment sites, newborns will be enrolled when they are \< 48 hours old. These newborns will have a study visit when they are 48 - 167 hours old. At the study visit, a BCB will be determined and blood will be drawn for study purposes for a TSB level. At Simultaneous Enrollment sites, newborns will be enrolled and have a study visit at the time of a blood draw (+/- 2 hours) for a TSB level that is being obtained for clinical purposes. Newborns will be 0-191 hours old.

Based on this trial design, predict the completion outcome and termination type (if applicable).